CM
XERS icon

Caption Management’s Xeris Biopharma Holdings XERS Stock Holding History

Caption Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Sell
280,000
-123,400
-31% -$788K 0.01% 867
2026
Q1 		$2.34M Buy
403,400
+280,000
+227% +$1.86M 0.01% 780
2025
Q4 		$969K Buy
+123,400
New +$971K 0.01% 1065
2024
Q1 		– Sell
-44,400
Closed -$104K – 1718
2023
Q4 		$104K Hold
44,400
– – ﹤0.01% 1175
2023
Q3 		$82.6K Hold
44,400
– – ﹤0.01% 1165
2023
Q2 		$116K Buy
+44,400
New +$113K ﹤0.01% 973

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Caption Management's XERS Position: Q2 2026 in Review

Caption Management reduced its Xeris Biopharma Holdings (XERS) stake by 3.5% in Q2 2026, selling an estimated $45.6K and leaving 197,863 shares worth $1.57M. The position accounts for 0.01% of the portfolio, ranked #983.

Caption Management first reported a position in XERS in Q4 2021 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Caption Management held 197,863 shares of Xeris Biopharma Holdings worth $1.57M as of Q2 2026.
  • Caption Management sold 7,137 Xeris Biopharma Holdings shares in Q2 2026, an estimated $45.6K.
  • Xeris Biopharma Holdings made up 0.01% of Caption Management's portfolio in Q2 2026, its #983 holding.
  • Caption Management first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.